Cogent Biosciences, Inc.
COGT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$255,859 | -$192,410 | -$140,241 | -$72,273 |
| Dep. & Amort. | $4,351 | $3,588 | $5,878 | $147 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $39,740 | $30,621 | $18,368 | $11,686 |
| Change in WC | $11,596 | $11,442 | $751 | $2,020 |
| Other Non-Cash | -$7,619 | -$6,865 | -$3,394 | -$343 |
| Operating Cash Flow | -$207,791 | -$153,624 | -$118,638 | -$58,763 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$573 | -$2,796 | -$6,863 | -$1,719 |
| Net Acquisitions | $0 | $0 | $118 | $0 |
| Inv. Purchases | -$255,603 | -$348,803 | -$177,855 | $0 |
| Inv. Sales/Matur. | $294,452 | $253,775 | $60,000 | $0 |
| Other Inv. Act. | $0 | $0 | -$118 | $0 |
| Investing Cash Flow | $38,276 | -$97,824 | -$124,718 | -$1,719 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $213,336 | $161,819 | $161,945 | $38,006 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,115 | $1,717 | $1,613 | -$30 |
| Financing Cash Flow | $214,451 | $163,536 | $163,558 | $37,976 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $44,936 | -$87,912 | -$79,798 | -$22,506 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $53,229 | $141,141 | $220,939 | $243,445 |
| End Cash | $98,165 | $53,229 | $141,141 | $220,939 |
| Free Cash Flow | -$208,364 | -$156,420 | -$125,501 | -$60,482 |